Artivion | CRY - Gross Profit On Sales


Artivion reported $73.14M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.65B 787M Jun/2026
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 44.78M 2.93M Sep/2025
Artivion USD 73.14M 1.25M Dec/2025
AtriCure USD 109.31M 3.97M Mar/2026
Baxter International USD 1.14B 251M Jun/2026
Becton, Dickinson and Co. USD 2.32B 161M Jun/2026
Boston Scientific USD 3.82B 210M Jun/2026
Edwards Lifesciences USD 1.35B 62.6M Jun/2026
Inogen USD 41.34M 1.39M Sep/2024
Integra LifeSciences USD 215.97M 2.77M Jun/2026
J&J USD 18.55B 1.31B Jun/2026
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 153.28M 4.76M Dec/2025
Pfizer USD -248M 11.29B Jun/2026
ResMed USD 861.22M 29.76M Jun/2026
Stryker USD 4.5B 688M Jun/2026
Tandem Diabetes Care USD 144.78M 7.99M Jun/2026
Teleflex USD 331.71M 24.28M Jun/2026
Terumo JPY 178.54B 29.52B Jun/2026
Trinity Biotech USD 6.47M 1.59M Sep/2025